Γ

SynBioBeta Speaker

Joshua Meier

CEO & Co-founder

Chai Discovery

May 2026, SynBioBeta

Speaker

Joshua Meier is the co-founder and CEO of Chai Discovery, a biotech company building frontier artificial intelligence to predict and reprogram the interactions between biochemical molecules. Prior to founding Chai, Joshua was the Chief AI Officer at Absci, where he spearheaded the company's transformation into AI Drug Discovery and built robust departments of top-tier AI scientists and engineers. Prior to Absci, Joshua was a senior researcher at Facebook AI Research, where he co-founded and led the platform for evolutionary-scale protein language modeling. The panel Joshua is speaking on will focus on the topic of how AI is reshaping how biopharma discovers, develops, and advances therapeutic agents across the full lifecycle, from early design to translational strategy and clinical asset development.

SynBioBeta 2026 Tickets are Live

Confirmed Speakers

Previous Speakers Include

Join for the latest
SynBioBeta event updates.

Join for the latest SynBioBeta event updates.